Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Michael Naughton

Washington University, Department: Internal Medicine/medicine

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Astrazeneca

Disclosed Value
Listed Reason
Payment for services (e.g., consulting fees, honoraria, paid authorship)

NA

Listed Research Project
Washington University/ Siteman Cancer Center Lead Academic Site

SCC is the only NCI-designated Comprehensive Cancer Center in Missouri or Southern Illinois and it is the leading oncology treatment facility within th St. Louis metropolitan area. Participation in the NCTN allows WU/SCC physicians to offer a broad range of clinical trials to patients with all types and stages of cancer and also provides an opportunity for investigators to confirm preliminary institutional findings regarding new cancer treatments, diagnostic tools, and prognostic markers in large numbers of patients.

Filed on June 09, 2018.

Tell us what you know about Michael Naughton's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
Michael Naughton Washington University Conflict of Interest Genentech $80,000 - $99,999
Michael Naughton Duke University Conflict of Interest Genentech $40,000 - $59,999
Michael Naughton Washington University Conflict of Interest Novartis $80,000 - $99,999
Michael Naughton Washington University Conflict of Interest Pfizer $20,000 - $39,999
Michael Naughton Washington University Conflict of Interest Celgene $20,000 - $39,999
Michael Naughton Washington University Conflict of Interest Genentech $80,000 - $99,999
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page